Raymond James analyst Christopher Raymond said the appointment of Ludwig Hantson, PdD as Alexion's new CEO will result in less drama, and more execution going forward. Raymond said some investors may be disappointed in that this may reduce the likelihood of a takeout, but he never saw this has a highly likely scenario. The analyst believes a turnaround is in the making and remains a buyer as this plays out given strong volume-driven growth from commercial products and upcoming catalysts, including Soliris MG approval. Raymond rates Alexion a Strong Buy.